These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35640798)

  • 1. Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting.
    Reolid A; Armesto S; Sahuquillo-Torralba A; Torres T; Feltes R; Vilarrasa E; Belinchón I; Cueva P; Rodríguez L; Romero-Maté A; Vidal D; Coto-Segura P; Herrera-Acosta E; Riera-Monroig J; Salgado L; Llamas-Velasco M; Daudén E
    J Am Acad Dermatol; 2022 Sep; 87(3):705-709. PubMed ID: 35640798
    [No Abstract]   [Full Text] [Related]  

  • 2. Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study.
    Galluzzo M; Talamonti M; Atzori L; Bardazzi F; Campanati A; Di Cesare A; Diotallevi F; Flori ML; Mugheddu C; Offidani A; Piaserico S; Russo F; Sacchelli L; Bianchi L; Prignano F
    Expert Opin Biol Ther; 2022 Apr; 22(4):547-554. PubMed ID: 35043741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment with secukinumab in a patient with generalized pustular psoriasis preceded by palmoplantar lesions.
    Sawai N; Kawakami Y; Tachibana K; Nomura H; Miyake T; Yokoyama E; Hirai Y; Morizane S
    J Dermatol; 2023 Dec; 50(12):e413-e414. PubMed ID: 37577828
    [No Abstract]   [Full Text] [Related]  

  • 4. Palmoplantar pustulosis emerged on a case of generalized pustular psoriasis successfully treated by secukinumab.
    Honma M; Nozaki H; Hayashi K; Iinuma S; Ishida-Yamamoto A
    J Dermatol; 2019 Dec; 46(12):e468-e469. PubMed ID: 31502309
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful secukinumab treatment of recalcitrant juvenile generalized pustular psoriasis.
    Nishida M; Takeichi T; Kono M; Imanishi A; Maekawa N; Akiyama M; Fukai K
    J Dermatol; 2020 Mar; 47(3):e77-e78. PubMed ID: 31907962
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of ustekinumab in palmoplantar pustulosis and palmoplantar pustular psoriasis.
    Bertelsen T; Kragballe K; Johansen C; Iversen L
    Int J Dermatol; 2014 Oct; 53(10):e464-6. PubMed ID: 24962808
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustained efficacy of secukinumab in patients with moderate-to-severe palmoplantar psoriasis: 2·5-year results from GESTURE, a randomized, double-blind, placebo-controlled trial.
    Gottlieb AB; Kubanov A; van Doorn M; Sullivan J; Papp KA; You R; Regnault P; Frueh JA
    Br J Dermatol; 2020 Apr; 182(4):889-899. PubMed ID: 31286480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study.
    Mrowietz U; Bachelez H; Burden AD; Rissler M; Sieder C; Orsenigo R; Chaouche-Teyara K
    J Am Acad Dermatol; 2019 May; 80(5):1344-1352. PubMed ID: 30716404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real world data from the use of secukinumab in the treatment of moderate-to-severe psoriasis, including scalp and palmoplantar psoriasis: A 104-week clinical study.
    Rompoti N; Katsimbri P; Kokkalis G; Boumpas D; Ikonomidis I; Theodoropoulos K; Rigopoulos D; Papadavid E
    Dermatol Ther; 2019 Sep; 32(5):e13006. PubMed ID: 31228319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3).
    Menter A; Warren RB; Langley RG; Merola JF; Kerr LN; Dennehy EB; Shrom D; Amato D; Okubo Y; Reich K
    J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1686-1692. PubMed ID: 28322474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of secukinumab in moderate to severe palmoplantar pustular psoriasis over 148 weeks: Extension of the 2PRECISE study.
    Mrowietz U; Bachelez H; Burden AD; Rissler M; Sieder C; Orsenigo R; Jagiello P
    J Am Acad Dermatol; 2021 Feb; 84(2):552-554. PubMed ID: 32565211
    [No Abstract]   [Full Text] [Related]  

  • 12. Infantile generalized pustular psoriasis with excellent response to secukinumab: A case report.
    Guevara BEK; Aquino JMRM; Diaz RBS; Contreras AIT; Jeng YC; Huang HY; Hsu CK; Pandita-Reyes BSB
    Exp Dermatol; 2023 Aug; 32(8):1296-1298. PubMed ID: 36847294
    [No Abstract]   [Full Text] [Related]  

  • 13. The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review.
    Sanchez IM; Sorenson E; Levin E; Liao W
    Dermatol Ther (Heidelb); 2017 Dec; 7(4):425-446. PubMed ID: 29143230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secukinumab-induced paradoxical hidradenitis suppurativa.
    Navarro-Triviño FJ; Sanchez-Parera R; Ruiz-Villaverde R
    Dermatol Ther; 2020 Jan; 33(1):e13150. PubMed ID: 31670893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First emergence of pyoderma gangraenosum, palmoplantar pustulosis and sacroiliitis in a psoriasis patient associated with switching from secukinumab to brodalumab.
    Sadik CD; Thieme M; Zillikens D; Terheyden P
    J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):e406-e407. PubMed ID: 31131924
    [No Abstract]   [Full Text] [Related]  

  • 16. Recalcitrant annular pustular psoriasis associated with psoriatic arthritis successfully treated with secukinumab.
    Herrero-Moyano M; Capusan TM; Martínez-Mera C; Llamas-Velasco M; Daudén E
    JAAD Case Rep; 2018 Sep; 4(8):842-844. PubMed ID: 30246137
    [No Abstract]   [Full Text] [Related]  

  • 17. Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE, a randomized controlled trial.
    Gottlieb A; Sullivan J; van Doorn M; Kubanov A; You R; Parneix A; Hugot S; Milutinovic M
    J Am Acad Dermatol; 2017 Jan; 76(1):70-80. PubMed ID: 27707593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of recalcitrant palmoplantar pustular psoriasis with sequential use of infliximab and adalimumab.
    Yawalkar N; Hunger RE
    Dermatology; 2009; 218(1):79-83. PubMed ID: 18974629
    [No Abstract]   [Full Text] [Related]  

  • 19. Local injection of low-dose ixekizumab for the treatment of palmoplantar pustular psoriasis.
    He F; Long F; Yin Z; Yin Z
    Int J Dermatol; 2022 Jun; 61(6):742-743. PubMed ID: 35347721
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term continuation with secukinumab in psoriasis: association with patient profile and initial psoriasis clearance.
    Ferrières L; Konstantinou MP; Bulai Livideanu C; Hegazy S; Tauber M; Amelot F; Paul C
    Clin Exp Dermatol; 2019 Oct; 44(7):e230-e234. PubMed ID: 31055846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.